🔓 Unlock the full profile of Mr.M.Madan Mohan Reddy (Aurobindo Pharmaceuticals), including verified contact details, financial insights, and professional associations.
See Mr.M.Madan Mohan Reddy Full ProfileBelow are the ✅ Verified Contact Details to help you connect directly:
Email: mr.*****@aur******.com
Mobile: 70792*****
Estimated Net Worth 💰 : ₹0 – ₹500+ Cr (approx. $0 – $60M)
Key Insights You Should Know About This Individual
- M. Madan Mohan Reddy serves as the Whole-time Director at Aurobindo Pharma Limited, overseeing formulation manufacturing operations and ensuring compliance with regulatory standards in the pharmaceutical sector.
- He has extensive expertise in organic chemistry, significantly contributing to the company's development and manufacturing processes.
- Under his leadership, Aurobindo Pharma has made strides in enhancing its production capabilities and expanding its global market presence.
- Madan Mohan Reddy's role involves managing crucial regulatory affairs, which are vital for maintaining the company's compliance in a highly regulated industry.
- He has been featured in discussions about health checks and wellness, reflecting his commitment to corporate health initiatives and employee welfare at Aurobindo Pharma.
- Reddy's experience is showcased in professional platforms like LinkedIn, where he connects with a broad network of industry professionals.
- He is represented on platforms that highlight his professional journey and contributions to Aurobindo, helping to position the company as a leader in pharmaceuticals.
| CIN/LLP | Company Name | Designation | Appointment Date |
|---|---|---|---|
| AAH-2286 | Crest Excipients Llp | Designated Partner | 25 Aug 2016 |
| L24239TG1986PLC015190 | Aurobindo Pharma Ltd | Whole-time director | 01 Jan 2013 |
| U24110TG2020PTC140190 | Curateq Biologics Private Limited | Director | 25 Apr 2020 |
| U24230TG2022PTC166946 | Theranym Biologics Private Limited | Director | 21 Aug 2023 |
| U24232TG2013PLC087101 | Curepro Parenterals Limited | Director | 21 Aug 2013 |
| U24239TG2020PTC141428 | Eugia Steriles Private Limited | Director | 05 Jul 2020 |
| U24297TG2013PLC087048 | Eugia Pharma Specialities Limited | Director | 17 Apr 2013 |
| U24297TG2021PTC156684 | Auro Vaccines Private Limited | Director | 08 Nov 2021 |
| U24299TG2020PTC142578 | Aurozest Private Limited | Director | 06 Aug 2020 |
| U24299TG2021PTC148856 | Eugia Sez Private Limited | Director | 20 Feb 2021 |
| U25203TG2012PTC084731 | Oremsi Plastics Private Limited | Director | 11 Dec 2012 |
| U29219TG1993PTC016451 | Pravesha Industries Private Limited | Director | 24 Aug 2018 |
| U74999TG2009PTC109591 | Auronext Pharma Private Limited | Director | 24 Aug 2021 |
| CIN/LLP | Company Name | Designation | Appointment Date | End Date |
|---|---|---|---|
| U24116TG2006PLC051171 | Apl Research Centre Limited | Director | 24 Aug 2015 | 02 February 2021 |
| U24232MH2012PTC333420 | Crest Cellulose Private Limited | Director | 22 Feb 2012 | 04 July 2022 |
| U24232TG2013PLC091383 | Aurozymes Limited | Director | 24 Aug 2015 | 02 February 2021 |
| U24239TG2004NPL043058 | Pharmaceuticals Export Promotion Council Of India | Director | 03 Mar 2016 | 25 April 2018 |
| U24239TS2004PLC184306 | Gls Pharma Limited | Director | 30 Sep 2022 | - |
| U26100TG2009PTC065810 | Sgd Pharma India Private Limited | Director | 13 Nov 2009 | 17 November 2021 |
| U45100TG2012PLC081892 | Raidurgam Developers Limited | Director | 24 Aug 2015 | 15 December 2017 |
| U74900TG2010PTC069202 | Sharp International Products Private Limited | Director | 03 Sep 2010 | 11 February 2013 |
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | Aurobindo Pharma Ltd. | Whole-time Director | 6.0 Cr | 14.9 % |
| 2023 | Aurobindo Pharma Ltd. | Executive Director | 5.2 Cr | 0.0 % |
| 2022 | Aurobindo Pharma Ltd. | Whole-time Director | 5.2 Cr | 0.0 % |
| 2021 | Aurobindo Pharma Ltd. | Whole-time Director | 5.2 Cr | 28.7 % |
| 2020 | Aurobindo Pharma Ltd. | Whole-time Director | 4.1 Cr | 52.0 % |
| 2019 | Aurobindo Pharma Ltd. | Whole-time Director | 2.7 Cr | 0.1 % |
| 2018 | Aurobindo Pharma Ltd. | Whole-time Director | 2.7 Cr | 0.7 % |
| 2017 | Aurobindo Pharma Ltd. | Whole-time Director | 2.7 Cr | 73.9 % |
| 2016 | Aurobindo Pharma Ltd. | Whole-time Director | 1.5 Cr | - |